• Brilique 60 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  TICAGRELOR	60 mg

  ATC: B01A B01AC B01AC24

• Brilique 90 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  TICAGRELOR	90 mg

  ATC: B01A B01AC B01AC24

• Brilique 90 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  TICAGRELOR	90 mg

  ATC: B01A B01AC B01AC24

• Brilique 90 mg orodispersible tablets

  Form: tablets, buccodispersable

  Active substance	Dosage
  TICAGRELOR	90 mg

  ATC: B01A B01AC B01AC24

• Calquence 100 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  ACALABRUTINIB MALEATE	129 mg

  ATC: L01E L01EL L01EL02

• Daxas 250 micrograms tablets

  Form: tablets

  Active substance	Dosage
  ROFLUMILAST	250 µg

  ATC: R03D R03DX R03DX07

• Daxas 500 micrograms film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  ROFLUMILAST	500 µg

  ATC: R03D R03DX R03DX07

• Ebymect 5 mg/1,000 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  DAPAGLIFLOZIN	5 mg
  METFORMIN HYDROCHLORIDE	1005 mg

  ATC: A10B A10BD A10BD15

• Ebymect 5 mg/850 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  DAPAGLIFLOZIN	5 mg
  METFORMIN HYDROCHLORIDE	854 mg

  ATC: A10B A10BD A10BD15

• Edistride 10 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  DAPAGLIFLOZIN	10 mg

  ATC: A10B A10BK A10BK01

• Fasenra 30 mg solution for injection in pre-filled pen

  Form: solution for injection in pre-filled pen

  Active substance	Dosage
  BENRALIZUMAB	30 mg

  ATC: R03D R03DX R03DX10

• Fasenra 30 mg solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  BENRALIZUMAB	30 mg

  ATC: R03D R03DX R03DX10

• Faslodex 250 mg/5 ml solution for injection

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  FULVESTRANT	250 mg

  ATC: L02B L02BA L02BA03

• Fluenz nasal spray suspension

  Form: suspension, nasal spray

  Active substance	Dosage
  INFLUENZA VIRUS LIVE ATTENUATED REASSORTANT STRAIN SIMILAR TO A/VICTORIA/4897/2022 (H1N1) PDM09	7,0 ± 0,5 FFU
  INFLUENZA VIRUS LIVE ATTENUATED STRAIN SIMILAR TO A/CROATIA/10136RV/2023 H3N2 A/PERTH/722/2024 VIRUS MEDI 392611	7,0 ± 0,5 FFU
  Influenza virus live attenuated reassortant strain similar to B/Austria/1359417/2021	7,0 ± 0,5 FFU

  ATC: J07B J07BB J07BB03

• Forxiga 10 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  DAPAGLIFLOZIN PROPANEDIOL	12,3 mg

  ATC: A10B A10BK A10BK01

• Imfinzi 50 mg/ml concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  DURVALUMAB	120 mg

  ATC: L01F L01FF L01FF03

• Imfinzi 50 mg/ml concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  DURVALUMAB	500 mg

  ATC: L01F L01FF L01FF03

• Imjudo 20 mg/ml concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  TREMELIMUMAB	300 mg

  ATC: L01F L01FX L01FX20

• Koselugo 10 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  SELUMETINIB SULFATE	12,10 mg

  ATC: L01E L01EE L01EE04

• Koselugo 25 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  SELUMETINIB SULFATE	30,25 mg

  ATC: L01E L01EE L01EE04

• Lokelma 10 g powder for oral suspension

  Form: powder for preparation of oral suspension

  Active substance	Dosage
  SODIUM ZIRCONIUM CYCLOSILICATE	Igual a 10 g g

  ATC: V03A V03AE V03AE10

• Lokelma 5 g oral suspension powder

  Form: powder for preparation of oral suspension

  Active substance	Dosage
  SODIUM ZIRCONIUM CYCLOSILICATE	5 g

  ATC: V03A V03AE V03AE10

• Lynparza 100 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  OLAPARIB	100 mg

  ATC: L01X L01XK L01XK01

• Lynparza 150 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  OLAPARIB	150 mg

  ATC: L01X L01XK L01XK01

• Oneglyza 5 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SAXAGLIPTIN HYDROCHLORide	5 mg

  ATC: A10B A10BH A10BH03

• Onigliza 2.5 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SAXAGLIPTIN HYDROCHLORide	2,5 mg

  ATC: A10B A10BH A10BH03

• Saphnelo 300 mg concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  ANIFROLUMAB	300 mg

  ATC: L04A L04AG L04AG11

• Tagrisso 40 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  OSIMERTINIB MESILATE	47,7 mg

  ATC: L01E L01EB L01EB04

• Tagrisso 80 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  OSIMERTINIB MESILATE	95,4 mg

  ATC: L01E L01EB L01EB04

• Tezspire 210 mg solution for injection in pre-filled pen

  Form: solution for injection in pre-filled pen

  Active substance	Dosage
  TEZEPELUMAB	210 mg

  ATC: R03D R03DX R03DX11

• Trixeo Aerosphere 5 micrograms/7.2 micrograms/160 micrograms pressurised inhalation suspension in pressurised container

  Form: suspension for inhalation in pressurized container

  Active substance	Dosage
  FORMOTEROL FUMARATE DIHYDRATE	5 µg/pulsación
  GLYCOPYRRONIUM BROMIDE	9 µg/pulsación
  BUDESONIDE	160 µg/pulsación

  ATC: R03A R03AL R03AL11

• Wainzua 45 mg solution for injection in pre-filled pen

  Form: solution for injection in pre-filled pen

  Active substance	Dosage
  EPLONTERSEN SODIUM	47 mg

  ATC: N07X N07XX N07XX21

• Xigduo 5 mg/1000 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  DAPAGLIFLOZIN	5 mg
  METFORMIN HYDROCHLORIDE	1000 mg

  ATC: A10B A10BD A10BD15

• Xigduo 5 mg/850 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  DAPAGLIFLOZIN	5 mg
  METFORMIN HYDROCHLORIDE	850 mg

  ATC: A10B A10BD A10BD15